P

Proof Diagnostics, Inc.

16 employees

Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.

Basic info

Industry

medical equipment manufacturing

Sectors

Biotechnology
Bioscience
Research
Personal Health
Health Care
Lab Testing
Mobile Apps
Diagnostics
Product Management
COVID-19
Molecular Diagnostics
Wellness
RT-LAMP
Healthcare
Molecular Biology
Point of Care Clinics
CRISPR
Apps

Date founded

2020

Funding rounds raised

Total raised

$45M

from 4 investors over 4 rounds

P

Proof Diagnostics, Inc. raised $45M on April 7, 2022

Investors: F-Prime Capital Partners, Madrona Venture Group and ARCH Venture Partners

P

Proof Diagnostics, Inc. raised undisclosed on October 1, 2020

Investors: SV Angel

FAQ